Research Results
Beta Version
Use the search bar below to find studies, or apply one or more filters to narrow your results. See our list of keywords to guide your search.
Search by keyword
Select
Select
- All Risk Factors
- Air Pollution
- Alcohol
- Antimicrobials
- Artificial sweeteners
- Bisphenols
- Body Weight
- Breast Density
- Chemical Mixtures
- Chemicals in products
- Cleaning Products
- Diet
- Exercise
- Family History
- Furniture & Electronics
- Genetics
- Gut Health
- Hair Dye
- Hormones
- Inflammation
- Job
- Light at night
- Metals
- Neighborhood
- Night Shift Work
- Noise
- Non-stick Pans & Waterproof Gear
- Oral Contraceptives
- PAHs
- Parabens
- PCBs
- Personal Care Products
- Pesticides
- PFAS
- Pharmaceuticals
- Place-based
- Plastic
- Pregnancy & Breastfeeding
- Processed Food
- Puberty Age
- Race/Ethnicity
- Radiation
- Red meat
- Scented Products & Soft Plastic
- Sleeping Patterns
- Soda
- Stress
- Sugar
- Sunscreen
- Tobacco
- Vitamin D
Select
Select
Select
Select
Select the Chemical Agents
- All Chemical Agents
- 1,1,2,2-TCA
- 1,3-Butadiene
- Acrolein
- Aldrin
- Alkylphenols
- Antimicrobials
- Antimicrobials: QACs, Triclosan, Triclocarban
- Aromatic Amines
- Arsenic
- Artificial Sweeteners
- Atrazine
- Benzene
- Bisphenols
- Cadmium
- Chlordane
- Chlorpyrifos
- DDT
- Dibutyl Phthalate
- Dichlorvos
- Dieldrin
- Dioxins
- ell/
- Ethanol (alcohol)
- Ethyl Benzene
- Ethylene Oxide
- Flame Retardants
- Food
- Formaldehyde
- Glyphosate
- Heptachlor
- Hormones
- Insulin
- Lead
- Light at Night
- Mercury
- Metals
- Methoxyclor
- Naphthalene
- Night Shift Work
- Nitrogen Dioxide
- Noise
- Oral Contraceptives
- Organochlorine Pesticides
- Organophosphate Pesticides
- Ozone
- PAHs
- Parabens
- Particulate Matter
- PCBs
- Pesticides
- PFAS
- Phenols
- Phthalates
- Processed Food
- PVC
- Radiation: Ionizing
- Radiation: Non-Ionizing
- Soda
- Stress
- Sugar
- Tobacco
- Toluene
- Trichloroethylene
- Triclosan
- Ultraviolet Radiation
- UV Filters
- Vinyl Chloride
Select the Study Tags
Sort By
- Relevance
- Title (A to Z)
- Title (Z to A)
- Publication Year (Ascending)
- Publication Year (Descending)
- Authors (A to Z)
- Authors (Z to A)
2024
Environ Health Perspect
A nationwide study using CDC biomonitoring data found that California’s Proposition 65, which requires warnings about chemicals that cause cancer or reproductive harm, led to reduced exposures to listed chemicals across the entire United States, not just California. While blood and urine concentrations of 37 monitored chemicals generally declined over time, the researchers found evidence of problematic chemical substitution—for example, after bisphenol A (BPA) was listed, its concentrations dropped 15% but levels of the unlisted substitute bisphenol S (BPS) increased 20%. Californians generally had lower levels of harmful chemicals in their bodies compared to residents of other states, suggesting the law had additional protective effects. The findings indicate that transparency laws like Prop 65 can drive manufacturers to reformulate products nationwide, but regulations need to address entire chemical classes rather than individual substances to prevent companies from simply switching to similar but unlisted toxic chemicals.
2024
J Natl Cancer Inst
A large US study of nearly 197,000 women found that exposure to fine particulate matter air pollution (PM2.5) during the 1980s—when pollution levels were higher—was associated with an 8% increased risk of breast cancer overall, with each 10 µg/m³ increase in PM2.5 concentration linked to the elevated risk. The association was particularly strong for estrogen receptor-positive breast cancers, showing a 10% increased risk, while no association was found for estrogen receptor-negative tumors. This study provides important evidence that historical air pollution exposure, even decades before diagnosis, may contribute to breast cancer development, particularly for hormone-sensitive tumors, emphasizing the long-term health consequences of air quality and the benefits of pollution reduction efforts.
2023
J Endocrinol Invest
A comprehensive literature review examining environmental endocrine-disrupting chemicals (EDCs) and hormone-related cancers concludes that several EDCs can be definitively classified as carcinogenic, including dioxin and cadmium for breast and thyroid cancer, arsenic and dioxin for prostate cancer, and organochlorines for testicular cancer. The review highlights that fetuses and newborns are most vulnerable to endocrine disruption, with adverse effects potentially manifesting at different ages throughout life, making it difficult to assess the full health impact of EDC exposure. The authors emphasize that EDCs represent a major environmental health issue requiring effective prevention policies, increased public awareness, and protective measures—particularly for pregnant women—along with standardized testing criteria to evaluate the carcinogenic potential of new chemicals before they enter widespread use.
2024
Environ Int
A study of 1,031 pregnant women from the socioeconomically diverse CANDLE cohort in the urban South found that ultra-processed foods constituted 38.6% of participants’ diets on average, with each 10% higher dietary proportion of ultra-processed foods associated with 13.1% higher urinary concentrations of DEHP phthalate metabolites, while specific foods like hamburgers, French fries, soda, and cake showed 6-10.5% higher DEHP per standard deviation increase in consumption. Causal mediation analyses revealed that lower income and education levels were associated with 1.9% and 1.4% higher DEHP exposure respectively, mediated through increased ultra-processed food consumption, indicating that ultra-processed foods contribute to socioeconomic disparities in phthalate exposure during pregnancy. The findings demonstrate that consuming ultra-processed foods increases exposure to endocrine-disrupting phthalates from food contact materials, and because socioeconomic barriers can prevent dietary modifications, policies to reduce phthalates in food packaging and processing are needed rather than relying solely on individual dietary recommendations to reduce prenatal phthalate exposures.
2024
Environ Health Perspect
Researchers analyzed 279 chemicals known to cause mammary tumors in rodents and identified 642 additional chemicals that activate estrogen or progesterone signaling, finding that tumor-causing chemicals were significantly more likely to stimulate hormone production, activate estrogen receptors, or damage DNA—characteristics that likely increase breast cancer risk in humans. The study found that more mammary carcinogens worked by increasing hormone production than by directly activating estrogen receptors, with chemicals showing stronger hormone-disrupting effects being most likely to cause tumors, demonstrating a clear dose-response relationship. These findings suggest that hundreds of chemicals currently in use may pose unrecognized breast cancer risks and should not be assumed safe without specific testing for breast effects, with the strongest evidence chemicals prioritized for exposure reduction and improved testing methods needed to identify additional hazardous substances. The research provides a framework for identifying and regulating chemicals that may contribute to breast cancer through hormone disruption and genetic damage—mechanisms supported by both animal and human studies.
2023
Chemosphere
A community-based intervention study (REDUXE) examined the effects of discontinuing paraben and phthalate-containing personal care products over 28 days by collecting paired fine needle aspirates of breast tissue from healthy volunteers before and after intervention, finding striking reversal of cancer-associated phenotypes including PI3K-AKT/mTOR pathway alterations, autophagy, and apoptotic signaling networks, along with significant reductions in urinary paraben and phthalate metabolites. Post-intervention breast tissue showed “normalizing” changes in estrogen-modulated gene expression pathways, estrogen receptor alpha:beta ratios, and cell cycle S-phase fraction when treated with 17β-estradiol in vitro, demonstrating functional improvement in cellular responses. This paradigm-shifting study reveals that persistent exposure to xenoestrogens from daily-use personal care products produces unfavorable pro-carcinogenic cellular changes in human breast tissue that can be reversed through short-term avoidance, suggesting that reducing xenoestrogen exposure from consumer products may suppress cancer-promoting phenotypes and represents a viable approach for breast cancer prevention.
2023
Environ Pollut
A 2022 study tested 571 cash register receipts from U.S. retailers to assess endocrine-disrupting chemicals in thermal paper and compared findings to a 2017 study. Bisphenol S (BPS) was found in 85% of receipts, Pergafast 201 in 12%, and bisphenol A (BPA) in only 1%, indicating a shift away from BPA. National retailers were more likely than local ones to use non-bisphenol alternatives. These findings highlight potential health risks from handling receipts, as BPS and other chemicals can still pose significant exposure concerns.
2023
Environ Sci Technol
The following study discusses a strategic framework to improve how chemicals are managed in North America. The Essential-Use Approach is a policy that prioritizes restricting the use of chemicals based on necessity and safety. It proposes three guiding questions: Is the chemical essential to the product’s function? Is it the safest option? Is it necessary for health and safety? They also prioritize speed of assesments so that chemicals can be quickly phased out if evidence suggests danger to human health. This study is a call for change and aims to become a tool to simplify decision-making for regulating organizations, help businesses avoid liability related to harmful chemicals, and ultimately improve public health by ensuring only the safest substances are used in consumer products.
2021
Adv Pharmacol
A comprehensive review examining endocrine-disrupting chemicals (EDCs) in breast tissue concludes that hundreds of these environmental chemicals are entering human breast tissue and contributing to the global rise in breast cancer incidence through multiple biological mechanisms. Laboratory studies demonstrate that EDCs can activate all the established “hallmarks of cancer” in human breast cancer cells—even at concentrations measured in actual human breast tissue—with effects amplified when chemicals are present as mixtures rather than individually. The authors argue that EDCs must now be formally recognized as a breast cancer risk factor to enable prevention strategies that include reducing environmental chemical exposures, particularly given that the varied mixtures of EDCs found in individual breast tissues act through overlapping mechanisms to promote cancer development.
2013
Green Chemistry
Scientists have developed TiPED (Tiered Protocol for Endocrine Disruption), a voluntary five-tier testing system designed to help chemists identify hormone-disrupting properties in new chemicals during the design phase—before they enter consumer products—ranging from computer-based predictions to cell and animal studies. The protocol was created by experts in green chemistry and environmental health to broadly test whether new chemicals can mimic or block hormones or interfere with hormone signaling, which is critical for preventing endocrine disruption that can contribute to diseases like breast cancer. Testing of six known endocrine disruptors with different mechanisms of action successfully identified all of them, demonstrating the protocol’s effectiveness, though the system will continue evolving as scientific understanding advances. This tool represents an important shift toward preventing chemical hazards at the design stage rather than discovering them years later after widespread human exposure, which could significantly reduce public health risks including breast cancer.
2012
Environ Health Perspect
This study analyzed 213 everyday products, including cosmetics, cleaners, and personal care items, for endocrine-disrupting chemicals (EDCs) and asthma-related compounds. Testing revealed 55 chemicals, with fragranced products and sunscreens containing the highest levels. Vinyl products were also found to contain significant amounts of bis(2-ethylhexyl) phthalate (DEHP), a known EDC. Many harmful chemicals were not listed on product labels, limiting consumer ability to avoid them. These results highlight the presence of potentially harmful chemicals in commonly used products, raising concerns about their widespread use in household and personal care items.
2011
J Steroid Biochem Mol Biol
Bisphenol A (BPA) is a widely produced chemical used in plastics and food container linings, with frequent human exposure due to its leaching into food and beverages. BPA, a known endocrine disruptor, was initially deemed a weak estrogen but has shown potency comparable to estradiol, a form of estrogen, shown to affect multiple hormonal pathways. Studies on rodents reveal adverse effects at levels below and at the current acceptable daily intake, raising concerns about human health impacts about concentration. BPA’s estrogenic effects highlight the importance of investigating BPA’s complex, widespread impacts on health.
2007
Cancer
A comprehensive review found that while laboratory studies have identified numerous environmental chemicals that cause breast tumors in animals or mimic estrogen, human epidemiological evidence is strongest for PAHs (found in air pollution and grilled foods) and PCBs (banned industrial chemicals), particularly in women with certain genetic variations affecting how their bodies process these chemicals and hormones. Evidence linking dioxins and organic solvents to breast cancer is limited but suggestive, while many chemicals identified as mammary carcinogens in animal studies have never been investigated in human populations due to challenges in measuring past exposures and the decades-long delay between exposure and cancer diagnosis. The review argues that given these methodological limitations in human studies, policymakers should rely more heavily on animal and laboratory evidence to develop regulations that reduce chemical exposures, as waiting for definitive human proof may unnecessarily delay prevention strategies that could reduce breast cancer rates.